Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

Vista senzilla d'ítem
dc.contributor.authorDíaz González, Álvaro
dc.contributor.authorHernández Guerra, Manuel
dc.contributor.authorPérez Medrano, Indhira
dc.contributor.authorSapena, Víctor
dc.contributor.authorRiveiro-Barciela, Mar
dc.contributor.authorBarreira Díaz, Ana
dc.contributor.authorGómez, Elena
dc.contributor.authorMorillas, Rosa M.
dc.contributor.authorBarrio, María del
dc.contributor.authorEscudé, Laia
dc.contributor.authorMateos, Beatriz
dc.contributor.authorHorta, Diana
dc.contributor.authorGómez, Judith
dc.contributor.authorConde, Isabel
dc.contributor.authorFerre Aracil, Carlos
dc.contributor.authorEl Hajra, Ismael
dc.contributor.authorArencibía, Ana
dc.contributor.authorZamora, Javier
dc.contributor.authorFernández, Ainhoa
dc.contributor.authorSalcedo, Magdalena
dc.contributor.authorMolina, Esther
dc.contributor.authorSoria, Anna
dc.contributor.authorEstévez, Pamela
dc.contributor.authorLópez, Carmen
dc.contributor.authorÁlvarez Navascúes, Carmen
dc.date.accessioned2023-11-17T12:17:48Z
dc.date.issued2023-04-01
dc.description.abstractIn patients with non-severe acute or chronic autoimmune hepatitis (AIH) without cirrhosis, clinical practice guidelines recommend indistinct use of prednisone or budesonide. However, budesonide is infrequently used in clinical practice. We aimed to describe its use and compare its efficacy and safety with prednisone as first-line options.ca
dc.format.extent39 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1527-3350
dc.identifier.pmid36626622
dc.identifier.urihttps://hdl.handle.net/2445/203780
dc.language.isoengca
dc.publisherWolters Kluwer Healthca
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1097/hep.0000000000000018
dc.relation.ispartofHepatology, 2023, vol. 77, num. 4, p 1095-1105
dc.relation.urihttps://doi.org/10.1097/hep.0000000000000018
dc.rights(c) American Association for the Study of Liver Diseases, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationHepatitis
dc.subject.classificationMalalties autoimmunitàries
dc.subject.otherHepatitis
dc.subject.otherAutoimmune diseases
dc.titleBudesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administrationca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
HEP-22-0918.R2_Proof_hi.pdf
Mida:
1.1 MB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)